← Back to Search

Plant-based Therapy

Ginger exosomes for Irritable Bowel Syndrome

N/A
Waitlist Available
Led By Susan Galandiuk, MD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will test whether ginger can help reduce inflammation in people with inflammatory bowel disease.

Eligible Conditions
  • Irritable Bowel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in inflammation on Colonoscopy
Secondary outcome measures
Change in Subjective symptoms

Trial Design

3Treatment groups
Active Control
Group I: Ginger exosomesActive Control1 Intervention
Study mixture will be taken PO daily times 28 days Sigmoidoscopy and biopsy, blood work, quality of life questionnaire
Group II: CurcuminActive Control1 Intervention
Study mixture will be taken PO daily times 28 days Sigmoidoscopy and biopsy, blood work, quality of life questionnaire
Group III: Ginger exosomes plus curcuminActive Control1 Intervention
Study mixture will be taken PO daily times 28 days Sigmoidoscopy and biopsy, blood work, quality of life questionnaire

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor
337 Previous Clinical Trials
75,960 Total Patients Enrolled
Susan Galandiuk, MDPrincipal Investigator - University of Louisville
Baptist Health Louisville
University Wurzburg (Medical School)
Cleveland Clinic Fndn (Residency)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
BiomaterialsJournal
Edible Ginger-derived Nanoparticles: A Novel Therapeutic Approach for the Prevention and Treatment of Inflammatory Bowel Disease and Colitis-associated Cancer
Zhang, Mingzhen, Emilie Viennois, Meena Prasad, Yunchen Zhang, Lixin Wang, Zhan Zhang, Moon Kwon Han, et al.. 2016. “Edible Ginger-derived Nanoparticles: A Novel Therapeutic Approach for the Prevention and Treatment of Inflammatory Bowel Disease and Colitis-associated Cancer”. Biomaterials. Elsevier BV. doi:10.1016/j.biomaterials.2016.06.018.
clinicaltrials.govStudy
Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease
Susan Galandiuk 2018. "Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04879810.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top